179 related articles for article (PubMed ID: 23518204)
1. Cortactin is a sensitive biomarker relative to the poor prognosis of human hepatocellular carcinoma.
Zhao G; Huang ZM; Kong YL; Wen DQ; Li Y; Ren L; Zhang HY
World J Surg Oncol; 2013 Mar; 11():74. PubMed ID: 23518204
[TBL] [Abstract][Full Text] [Related]
2. Combining cortactin and CTTN detection with clinicopathologic features increases effectiveness of survival predictions for patients with resectable hepatocellular carcinoma.
Gang Z; Ya-Lin K; Dong-Qing W; Yu L; Li R; Hong-Yi Z
Clin Lab; 2013; 59(11-12):1343-52. PubMed ID: 24409670
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of HOXA1 correlates with poor prognosis in patients with hepatocellular carcinoma.
Zha TZ; Hu BS; Yu HF; Tan YF; Zhang Y; Zhang K
Tumour Biol; 2012 Dec; 33(6):2125-34. PubMed ID: 22864671
[TBL] [Abstract][Full Text] [Related]
4. High expression of thymosin beta 10 predicts poor prognosis for hepatocellular carcinoma after hepatectomy.
Wang H; Jiang S; Zhang Y; Pan K; Xia J; Chen M
World J Surg Oncol; 2014 Jul; 12():226. PubMed ID: 25037578
[TBL] [Abstract][Full Text] [Related]
5. High Expression of Neuropilin-1 Associates with Unfavorable Clinicopathological Features in Hepatocellular Carcinoma.
Zhang Y; Liu P; Jiang Y; Dou X; Yan J; Ma C; Fan Q; Wang W; Su F; Tang H; Su X
Pathol Oncol Res; 2016 Apr; 22(2):367-75. PubMed ID: 26563279
[TBL] [Abstract][Full Text] [Related]
6. IMP3 combined with CD44s, a novel predictor for prognosis of patients with hepatocellular carcinoma.
Hu S; Wu X; Zhou B; Xu Z; Qin J; Lu H; Lv L; Gao Y; Deng L; Yin J; Li G
J Cancer Res Clin Oncol; 2014 Jun; 140(6):883-93. PubMed ID: 24647926
[TBL] [Abstract][Full Text] [Related]
7. Up-regulation of long non-coding RNA Sox2ot promotes hepatocellular carcinoma cell metastasis and correlates with poor prognosis.
Shi XM; Teng F
Int J Clin Exp Pathol; 2015; 8(4):4008-14. PubMed ID: 26097588
[TBL] [Abstract][Full Text] [Related]
8. Ack1 overexpression promotes metastasis and indicates poor prognosis of hepatocellular carcinoma.
Lei X; Li YF; Chen GD; Ou DP; Qiu XX; Zuo CH; Yang LY
Oncotarget; 2015 Dec; 6(38):40622-41. PubMed ID: 26536663
[TBL] [Abstract][Full Text] [Related]
9. Fibulin-5 inhibits hepatocellular carcinoma cell migration and invasion by down-regulating matrix metalloproteinase-7 expression.
Tu K; Dou C; Zheng X; Li C; Yang W; Yao Y; Liu Q
BMC Cancer; 2014 Dec; 14():938. PubMed ID: 25494879
[TBL] [Abstract][Full Text] [Related]
10. S100A14 promotes the growth and metastasis of hepatocellular carcinoma.
Zhao FT; Jia ZS; Yang Q; Song L; Jiang XJ
Asian Pac J Cancer Prev; 2013; 14(6):3831-6. PubMed ID: 23886191
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of WWP1 promotes tumorigenesis and predicts unfavorable prognosis in patients with hepatocellular carcinoma.
Zhang XF; Chao J; Pan QZ; Pan K; Weng DS; Wang QJ; Zhao JJ; He J; Liu Q; Jiang SS; Chen CL; Zhang HX; Xia JC
Oncotarget; 2015 Dec; 6(38):40920-33. PubMed ID: 26506518
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of annexin A4 indicates poor prognosis and promotes tumor metastasis of hepatocellular carcinoma.
Chen W; Chen L; Cai Z; Liang D; Zhao B; Zeng Y; Liu X; Liu J
Tumour Biol; 2016 Jul; 37(7):9343-55. PubMed ID: 26779633
[TBL] [Abstract][Full Text] [Related]
13. miR-149 represses metastasis of hepatocellular carcinoma by targeting actin-regulatory proteins PPM1F.
Luo G; Chao YL; Tang B; Li BS; Xiao YF; Xie R; Wang SM; Wu YY; Dong H; Liu XD; Yang SM
Oncotarget; 2015 Nov; 6(35):37808-23. PubMed ID: 26498692
[TBL] [Abstract][Full Text] [Related]
14. Hint1 suppresses migration and invasion of hepatocellular carcinoma cells in vitro by modulating girdin activity.
Wu XS; Bao TH; Ke Y; Sun DY; Shi ZT; Tang HR; Wang L
Tumour Biol; 2016 Nov; 37(11):14711-14719. PubMed ID: 27623945
[TBL] [Abstract][Full Text] [Related]
15. Differential expression of IQGAP1/2 in Hepatocellular carcinoma and its relationship with clinical outcomes.
Xia FD; Wang ZL; Chen HX; Huang Y; Li JD; Wang ZM; Li XY
Asian Pac J Cancer Prev; 2014; 15(12):4951-6. PubMed ID: 24998570
[TBL] [Abstract][Full Text] [Related]
16. [OCT4 expression in hepatocellular carcinoma and its clinical significance].
Huang PZ; Lu CL; Li BK; Hong J; Huang L; Wang L; Zhang Y; Yuan YF
Chin J Cancer; 2010 Jan; 29(1):111-16. PubMed ID: 20038322
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of ARK5 is associated with poor prognosis in hepatocellular carcinoma.
Cui J; Yu Y; Lu GF; Liu C; Liu X; Xu YX; Zheng PY
Tumour Biol; 2013 Jun; 34(3):1913-8. PubMed ID: 23516026
[TBL] [Abstract][Full Text] [Related]
18. Gelsolin-like Actin-capping Protein (CapG) Overexpression in the Cytoplasm of Human Hepatocellular Carcinoma, Associated with Cellular Invasion, Migration and Tumor Prognosis.
Tsai TJ; Chao WY; Chen CC; Chen YJ; Lin CY; Lee YR
Anticancer Res; 2018 Jul; 38(7):3943-3950. PubMed ID: 29970516
[TBL] [Abstract][Full Text] [Related]
19. Cortactin and Exo70 mediated invasion of hepatoma carcinoma cells by MMP-9 secretion.
Zhao G; Zhang H; Huang Z; Lv L; Yan F
Mol Biol Rep; 2016 May; 43(5):407-14. PubMed ID: 27025610
[TBL] [Abstract][Full Text] [Related]
20. The HBx-CTTN interaction promotes cell proliferation and migration of hepatocellular carcinoma via CREB1.
Li Y; Fu Y; Hu X; Sun L; Tang D; Li N; Peng F; Fan XG
Cell Death Dis; 2019 May; 10(6):405. PubMed ID: 31138777
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]